Related by context. Frequent words. (Click for all words.) 70 evaluable patients 69 tumor shrinkage 68 annualized relapse 68 sustained virologic response 67 RECIST criteria 66 evaluable 66 plus methotrexate 66 tumor regression 65 nilotinib 65 laboratory abnormalities 65 mg BID 65 hematologic 64 dasatinib 64 imatinib 64 dose limiting toxicities 64 neoadjuvant chemotherapy 64 adalimumab 63 chemoradiation 63 discontinuations due 63 Secondary endpoints include 63 secondary endpoint 63 limiting toxicity 63 tumor recurrence 63 myelosuppression 63 Secondary endpoints 62 PROMACTA 62 FOLFIRI 62 events AEs 62 RECIST 62 febrile neutropenia 62 Secondary endpoints included 61 decitabine 61 thromboembolic events 61 nonresponders 61 median PFS 61 free survival PFS 61 dose cohorts 61 events SAEs 61 tamoxifen therapy 61 composite endpoint 61 SUTENT 61 dacarbazine 61 distant metastases 61 FOLFOX 61 peginterferon 61 chronic myeloid leukemia CML 61 plus ribavirin 60 plus prednisone 60 metastatic renal cell carcinoma 60 azacitidine 60 TORISEL 60 topotecan 60 peginterferon alfa 2a 60 seroconversion 60 liver metastases 59 sunitinib 59 biologic therapy 59 mcg kg 59 infliximab 59 temsirolimus 59 leukopenia 59 pramipexole 59 NRTI 59 Median survival 59 mitoxantrone 59 undetectable viral load 59 hypercalcemia 59 DAS# [002] 59 follicular lymphoma 59 viral suppression 59 bosentan 59 ACR# [002] 58 colectomy 58 HCV RNA 58 vandetanib 58 Taxotere ® 58 unresectable 58 carboplatin 58 COPAXONE R 58 adefovir 58 CD4 + cell 58 placebo p = 58 proteinuria 58 etanercept 58 rituximab 58 peginterferon alfa 2b 58 histologic 58 vertebral fracture 58 discontinuations 58 gefitinib 58 Rituximab 58 ACTEMRA 58 tocilizumab 58 entecavir 57 log# 57 myeloid 57 LVEF 57 relapsing remitting 57 Bevacizumab 57 DMARDs 57 Imatinib